Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study.
about
Primary Esophageal Extranasal NK/T Cell Lymphoma With Biphasic Morphology: A Case Report and Literature ReviewReview of the clinical research conducted by the Consortium for Improving Survival of Lymphoma of the Korean Society of Hematology Lymphoma Working PartyNew molecular insights into peripheral T cell lymphomasExtranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases.Diagnosis and management of extranodal NK/T cell lymphoma nasal type.Prognostic significance of peripheral monocyte count in patients with extranodal natural killer/T-cell lymphoma.Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience.High-dose methotrexate, etoposide, dexamethasone and pegaspargase (MEDA) combination chemotherapy is effective for advanced and relapsed/refractory extranodal natural killer/T cell lymphoma: a retrospective study.GDP (Gemcitabine, Dexamethasone, and Cisplatin) Is Highly Effective and Well-Tolerated for Newly Diagnosed Stage IV and Relapsed/Refractory Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.Efficacy and safety of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) regimen in newly diagnosed, advanced-stage extranodal natural killer/T-cell lymphoma: interim analysis of a phase 4 study NCT01501149.Single pleural relapse of a nasal-type extranodal natural killer/t-cell lymphoma: a case reportNK cell lymphoma, nasal type, with massive lung involvement: a case reportPrognostic markers in peripheral T-cell lymphomaExtranodal natural killer/T-cell lymphoma, nasal type, involving the skin, misdiagnosed as nasosinusitis and a fungal infection: A case report and literature review.Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma Study Group.Extranodal natural-killer/t-cell lymphoma, nasal typeCD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal typeSerum C-reactive protein (CRP) as a simple and independent prognostic factor in extranodal natural killer/T-cell lymphoma, nasal typeSerum levels of interleukin-9 correlate with negative prognostic factors in extranodal NK/T-cell lymphoma.Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferationsUtility of PET/CT in the diagnosis and staging of extranodal natural killer/T-cell lymphoma: a systematic review and meta-analysis.The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patientsA TNM Staging System for Nasal NK/T-Cell Lymphoma.Prognostic biomarkers in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy.High Pretreatment D-Dimer Levels Correlate with Adverse Clinical Features and Predict Poor Survival in Patients with Natural Killer/T-Cell Lymphoma.Increased serum levels of interleukin-10 predict poor prognosis in extranodal natural killer/T-cell lymphoma patients receiving asparaginase-based chemotherapyComplete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma.Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type.How to predict the outcome in mature T and NK cell lymphoma by currently used prognostic models?Tumor cell nuclear diameter and CD30 expression as potential prognostic parameter in patients with extranodal NK/T-cell lymphoma, nasal type.Five-year analysis from phase 2 trial of "sandwich" chemoradiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma.Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase.Fasting blood glucose is a novel prognostic indicator for extranodal natural killer/T-cell lymphoma, nasal typeThe pretreatment albumin to globulin ratio predicts survival in patients with natural killer/T-cell lymphomaDecreased apolipoprotein A-I level indicates poor prognosis in extranodal natural killer/T-cell lymphoma, nasal type.Extranodal nasal-type NK/T-cell lymphoma of the palate and paranasal sinuses.Consolidative treatment after salvage chemotherapy improves prognosis in patients with relapsed extranodal natural killer/T-cell lymphomaPrimary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma.Predicting the outcome in non-Hodgkin lymphoma with molecular markers.The spectrum of Epstein-Barr virus-associated lymphoproliferative disease in Korea: incidence of disease entities by age groups.
P2860
Q26800228-DBEDE1AE-5CD6-4E6E-BD76-FE53C9EF6C73Q27003188-33DD4E30-2CFC-489E-9ACD-23AF020C90A6Q27026081-2ACD6491-27EB-437A-885C-3A5953805B40Q30244110-F0EBC44F-DCFB-49D2-8C05-EE203DFAA2FEQ30249309-942DBB7B-35D2-4226-A145-E19076749C02Q31116522-3B1B1C9E-1A64-4AE4-9AED-6A9429AA89FFQ33395423-09C2905E-896E-4B80-825A-F68A9341B786Q33423016-89570480-75BE-4FB1-A92B-ED4362BE2BF6Q33429990-7546ABA7-C6ED-48EA-9D36-E7E1D2B02EEAQ33433689-5BCC71AD-D274-4C08-9713-45954D971531Q33612360-5D06225B-4610-4355-8AF8-AA9DF5E0EA45Q33906877-71363BE4-44A1-45D4-83EE-5A9352018D4BQ34166857-333A9A03-B6CF-4A54-AC88-403CB2358483Q34293085-03EC8B76-83C9-4BEA-B53D-B8EE67157BABQ34478430-46915066-11D0-4A40-9756-7DFDA2482301Q34479166-3DCDADAE-E756-40FA-BD4C-2256C626E6D7Q34650606-DE7A84A2-E958-479D-80FE-F024F6311424Q34749502-539B8892-FE5D-4E41-96EF-890FD0E7C5DDQ35145308-85E63C03-F988-4CEE-9CA2-15DBED0EDFF2Q35232848-27882EF5-E271-408C-B61C-A0E21869039FQ35530868-D841FE17-5A50-441E-87A1-936D46EAC938Q35624432-3C9CC11D-4860-4D94-86C0-630AB8626FB8Q35670806-F06A0DA7-AE92-4A21-8E2D-2F9BF394F170Q35713503-C17013CD-61C0-43A8-A4BC-D92B06302416Q35975572-883F4F9F-586E-4489-8995-96898C7F7F05Q36078298-C1D73D2C-6C32-4FAD-843D-C9124D9A5C54Q36156508-FC84EBB1-F658-412F-9221-5467AF047BBFQ36232164-0C1E6F23-4E82-4C52-B3DC-059B13DEC4B5Q36355093-A05777C0-D665-4988-891E-9E8C72EDD5EBQ36358059-C4A1FFE4-D758-4E95-8AAA-43767044A9D9Q36451579-55C48433-C811-4489-90EC-093C29A614C6Q36557585-9EEB7DF7-E736-460E-9D0A-8CB1D359811AQ36594091-0E86E046-4A9E-42D8-B6CE-3D01929E6CE6Q36663469-88150F74-D284-4430-82F2-8C92EE1016A5Q36716218-F12AA4E9-FCBB-4016-BA84-14512979BF2EQ36738758-5718EF22-B88F-479D-ADD8-B809889667D4Q36760583-D7ABB16F-6529-4346-96C3-3CF95A08C90FQ36765418-8EEAE0F4-F1E9-42DC-856F-98B4EB8E90F7Q36780164-6D46A8FC-C0A0-48DC-AB45-2EF23A748B6AQ36854176-41C0CA57-6D86-4609-94F7-4CDA1AF233B2
P2860
Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Extranodal natural killer T-ce ...... trospective multicenter study.
@ast
Extranodal natural killer T-ce ...... trospective multicenter study.
@en
Extranodal natural killer T-ce ...... trospective multicenter study.
@nl
type
label
Extranodal natural killer T-ce ...... trospective multicenter study.
@ast
Extranodal natural killer T-ce ...... trospective multicenter study.
@en
Extranodal natural killer T-ce ...... trospective multicenter study.
@nl
prefLabel
Extranodal natural killer T-ce ...... trospective multicenter study.
@ast
Extranodal natural killer T-ce ...... trospective multicenter study.
@en
Extranodal natural killer T-ce ...... trospective multicenter study.
@nl
P2093
P356
P1476
Extranodal natural killer T-ce ...... trospective multicenter study.
@en
P2093
Cheolwon Suh
Chulwon Jung
Dae Ho Lee
Hyo Jin Kim
Hyuk-Chan Kwon
Jae Hoon Lee
Jeeyun Lee
Jinny Park
Jooryung Huh
Jung Han Kim
P304
P356
10.1200/JCO.2005.04.1384
P407
P577
2005-12-27T00:00:00Z